PFPhoenix Financial Ltd.

Institutional investor · Portfolio as of Q4 2023

SEC EDGAR SourceSEC Filings

Top Holdings349 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
XLFXLF
ETF

FINANCIAL SELECT SECTOR SPDR

13.2M$555.6M9.2%$31.98+14.16%
17 qtrssince 2019-Q4
Decreased
0
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

34.4M$404.3M6.7%$9.32+12.03%
18 qtrssince 2019-Q3
Decreased
0
NICENICE
ADR

NICE LTD - SPON ADR

1.3M$304.7M5.0%$174.88+14.08%
18 qtrssince 2019-Q3
Decreased
0
XOPXOP
ETF

SPDR SERIES TRUST

1.8M$282M4.7%$130.46-0.09%
4 qtrssince 2023-Q1
Increased
91
KREKRE
ETF

SPDR SERIES TRUST

3.5M$209.6M3.5%$49.590.00%
1 qtr
New
85

AMAZON.COM INC

1M$177.2M2.9%$127.12+19.52%
2 qtrssince 2023-Q3
Decreased
0

TARGET CORP

974,439$156M2.6%$99.07+30.14%
3 qtrssince 2023-Q2
Decreased
0

PALO ALTO NETWORKS INC

285,495$151.9M2.5%$104.84+40.64%
13 qtrssince 2020-Q4
Decreased
0

UNION PACIFIC CORP

525,985$145.5M2.4%$189.81+23.65%
4 qtrssince 2023-Q1
Decreased
0
RSPSRSPS
ETF

INVESCO EXCHANGE TRADED FD T

3.9M$136.3M2.3%$28.59+3.97%
4 qtrssince 2023-Q1
Decreased
0
XBIXBI
ETF

SPDR S&P BIOTECH ETF

1.3M$131.6M2.2%$83.13+6.86%
10 qtrssince 2021-Q3
Decreased
0

ORACLE CORP

1.1M$128M2.1%$103.37-0.49%
4 qtrssince 2023-Q1
Decreased
0
XLVXLV
ETF

HEALTH CARE SELECT SECTOR SPDR

828,551$125.8M2.1%$123.22+7.07%
16 qtrssince 2020-Q1
Decreased
0
IXJIXJ
ETF

ISHARES TR

1.3M$122.7M2.0%$80.31+4.89%
3 qtrssince 2023-Q2
Decreased
0

NVIDIA CORP

207,960$115M1.9%$44.07+12.30%
10 qtrssince 2021-Q3
Increased
76
INDAINDA
ETF

ISHARES MSCI INDIA ETF

1.9M$102.1M1.7%$40.50+19.65%
5 qtrssince 2022-Q4
Decreased
0

TOWER SEMICONDUCTOR LTD

2.8M$96.9M1.6%$30.39+0.44%
18 qtrssince 2019-Q3
Decreased
0
KOFKOF
ADR

COCA-COLA FEMSA SAB-SP ADR

862,522$91.7M1.5%$74.73+19.62%
4 qtrssince 2023-Q1
Decreased
0

ICL GROUP LTD

15.7M$88.6M1.5%$5.95-20.29%
15 qtrssince 2020-Q2
Decreased
0

BANK OF AMERICA CORP

2.3M$87.3M1.4%$25.89+23.95%
2 qtrssince 2023-Q3
Decreased
0
$6B
AUM
349
Positions
Q4 2023
Filing
Rating · 3.5
Quarterly Portfolio Change
-7%Q3'22$4.5B+14%Q4'22$5.2B-13%Q1'23$4.5B+9%Q2'23$4.9B+123%Q3'23$10.9B-45%Q4'23$6B
Activity profile
$ moved · Q4'23
New6%Increased8%Decreased73%Exited14%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.5 years
<1Q11%1-4Q12%1-2Y11%2Y+65%

Phoenix Financial Ltd. manages $6B across 349 positions as of Q4 2023. Top holdings: XLF (9.2%), TEVA (6.7%), NICE (5.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q4 2023 Summary

Active quarter - 69 new positions, 37 exits, 16 increased. Top move: XOP (INCREASED, conviction 91). Portfolio: $6.0B across 349 positions.

Top holdings by portfolio weight

Total AUM$6B
XLF9.19%
TEVA6.69%
NICE5.04%
XOP4.66%
KRE3.47%
AMZN2.93%
TGT2.58%
PANW2.51%
UNP2.41%
RSPS2.25%
Other2.18%

Portfolio allocation by GICS sector

Sectors11
Unknown38.96%
Technology26.79%
Healthcare9.50%
Consumer Cyclical5.13%
Industrials4.77%
Consumer Defensive4.61%
Communication Services3.62%
Financial Services3.32%
Basic Materials1.94%
Utilities0.69%
Other0.67%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track RecordNo data
Conviction44
Concentration64
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
CLBTCLBTCELLEBRITE DI LTD
Q2 2025 Q2 2026+5.4M shares+$74.8M
4Q
GEVGEVGE VERNOVA LLC
Q3 2025 Q2 2026+5,964 shares+$8M
4Q
TELTELTE CONNECTIVITY PLC
Q3 2025 Q2 2026+2,103 shares+$473,241
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used